3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
139
Sarcoma
32
Gastrointestinal
9
Thoracic
6
Lymphoid
5
Gynecologic
5
Genitourinary
4
Dermatologic
4
Breast
4
Head & Neck
3
Endocrine
3
Plasma cell
2
Other solid neoplasm
2
Other hematologic neoplasm
2
NET
1
Conditions
Neuroendocrine Tumors
43
Carcinoma, Neuroendocrine
8
Gastro-enteropancreatic neuroendocrine tumor
7
Sarcoma
6
Carcinoid Tumor
6
Stomach Neoplasms
5
Small Cell Lung Carcinoma
5
Paraganglioma
5
Neoplasms
5
Prostatic Neoplasms
4
Pheochromocytoma
4
Neoplasm Metastasis
4
Lung Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma
4
Thyroid Neoplasms
3
Neuroblastoma
3
Carcinoma, Renal Cell
3
Thyroid Diseases
2
Thoracic Neoplasms
2
Respiratory Tract Neoplasms
2
Respiratory Tract Diseases
2
Ovarian Neoplasms
2
Neuroectodermal Tumors
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Meningioma
2
Medulloblastoma
2
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Glioma
×
NET
×
Clear all
NCT06607692
2026-04-14
LUPARPED
Fundación de investigación HM
Phase 1/2
Recruiting
25 enrolled